Stock·NYSE·Financial Services
BlackRock, Inc. (BLK)
- Market cap
- $183.22B
- P/E
- 25.68
- Dividend yield
- 1.99%
- Street target
- $1,310.00median of 18 analysts
- 52-week range
- $917.39 $1,187.17
BLK stock forecast today
Where BLK stands today, and what CleaRank Financial AI makes of it.
BLK at a glance
BlackRock, Inc. (BLK): Buy, 70/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($1,103.45 and $1,062.34).
- Earnings BLK beat estimates in 6 of the 6 reports in our data, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $296.0M and made no open-market purchases over the last 18 months.
- Valuation P/E of 25.7 against 16.5 for the Financial Services sector: a premium to peers (+56%).
Figures as of October 26, 2026.
CleaRank Financial AI
BlackRock, Inc. (BLK) carries a CleaRank rating of Buy and a model score of 70/100.
Trend contributes the most to that score: the price is 6.15% above its 200-day average and 2.19% above its 50-day, while the 50-day sits 3.87% above the 200-day. Valuation is the largest drag, with the P/E of 25.68 55.6% above the sector median (a premium to peers) and the P/S of 6.37 67.6% above the sector median. The 50-day average is $1,103.45 and the 200-day is $1,062.34. The price fell 0.79% over the past year.
Only on CleaRank
Figures we compute ourselves from BLK's own price, earnings and insider-filing history. Tap one to see it in context.
BLK stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $1,127.66 is 2.2% above the 50-day simple moving average of $1,103.45.Price above its 200-day average ›
The price is 6.1% above the 200-day simple moving average of $1,062.34.50-day average above the 200-day ›
The 50-day average ($1,103.45) is 3.9% above the 200-day average ($1,062.34), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 78% of its 52-week range, between $917.39 and $1,187.17.
BLK share price
Pick a period: each tab shows how far BLK has moved over it, to the last close.
Today's trading
Where BLK sits inside today's range and its 52-week range.
BLK fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 25.68 is 55.6% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 6.37 is 67.5% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $6.9B on revenue of $28.5B, a net margin of 24.2%.Beat estimates in most recent reports ›
BLK beat the EPS estimate in 6 of the 6 reports in our data.Pays a dividend ›
The trailing dividend yield is 1.99%, or $22.40 a share a year.
Key statistics
The headline figures for BLK.
As of October 26, 2026, BLK trades at $1,127.66, with a market value of $183.22B, a P/E ratio of 25.68 and a dividend yield of 1.99%.
What the numbers say
CleaRank Financial AI's reading of BLK's valuation, growth and risks.
BLK's P/E of 25.68 is 54.3% above the 16.5 median for Financial Services stocks, a level that marks it as a premium to peers. Measured on sales, its P/S of 6.37 is 67.6% above the sector median of 3.8. The company carries a market value of $183.2B, and its trailing earnings come to $43.92 per share.
Profitability shows a net margin of 24.22% and an operating margin of 37.90%, with a return on equity of 9.02%, below the sector median of 13.8%. Debt-to-equity of 0.23 and a trailing dividend yield of 1.99% ($22.40 a share a year) round out the fundamentals.
BlackRock, Inc. (BLK) beat expectations in its October 14, 2026 report by 11.40%, posting EPS of $15.93 against an estimate of $14.30. Investors responded in kind, and the stock climbed 4.38% in the next session.
BLK has topped the EPS estimate in all 6 reports in our data, yet the stock fell in the first session after 2 of those 6 beats. Analysts expect EPS of $57.86 for this fiscal year and $64.83 for next year, with the current-year figure implying growth of 20.3%.
A premium valuation leaves less room for error. BLK's P/E of 25.68 sits 55.6% above the sector median, a premium to peers. The average daily move is 1.44%, and the beta against the S&P 500 is 1.42. Insiders sold $296.0M of stock over the last 18 months and bought nothing on the open market. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases.
BLK against the Financial Services sector
How BLK compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: BLK trades at a significant premium to sector peers (+56%), suggesting market expectations for superior growth or market position.
Return vs XLF: Since May 14, 2025, BLK has gained 16.6% against a gain of 9.9% for XLF.
Performance against XLF
BLK and the Financial Services sector fund over the same days.
Revenue and earnings
How much BLK sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); BLK reported again on October 14, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 18.7% in FY2025 to $24.2B, from $20.4B a year earlier.
Profit margin: The net margin was 24.5% in FY2025, down from 31.9% the year before.
Profitable: BLK earned $5.9B in FY2025.
Earnings reality check
Did BLK beat what analysts expected, and how did the stock react?
Earnings record: BLK beat the analyst estimate in 6 of the 6 reports in our data.
Market reaction: The stock fell in the first session after 2 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 14, 2026after close | $14.30 | $15.93 | +11.40% | +4.38% | +7.06% |
| Jul 15, 2026after close | $12.69 | $13.91 | +9.61% | -0.58% | -3.36% |
| Apr 14, 2026after close | $11.46 | $12.53 | +9.34% | -0.57% | -1.11% |
| Oct 14, 2025after close | $11.29 | $11.55 | +2.30% | +0.70% | -5.38% |
| Jul 15, 2025after close | $10.81 | $12.05 | +11.47% | +3.45% | +5.18% |
| Apr 11, 2025after close | $10.13 | $11.30 | +11.55% | +1.27% | -2.82% |
As of October 26, 2026, BLK has beaten the analyst EPS estimate in 6 of the 6 reports in our data and fell in the first trading session after 2 of those beats; its latest report, on October 14, 2026, came in 11.40% above the estimate and the stock moved +4.38% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
BLK AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 57.4, in neutral territory.RSI above 50 ›
An RSI of 57.4 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of BLK
The score, the reasoning behind it, and what could move the price next.
BlackRock, Inc. (BLK) is trending up. The stock sits at $1,127.66, which is 2.19% above its 50-day average of $1,103.45 and 6.15% above its 200-day average of $1,062.34. Its position is 78% of the way across its 52-week range, and the price is 5.01% below the 52-week high of $1,187.17.
Recent gains sit against a weaker longer record: the price rose 3.81% over the past month, rose 6.17% over the past three months and fell 0.79% over the past year. The price rose 0.84% in the last session on volume 47.3% below its average. On momentum, the 14-day RSI reads 57.4, in the neutral zone, with the MACD line positive.
Earnings beat ›
The October 14, 2026 report beat the EPS estimate by 11.40%, and the share price rose 4.38% in the first session after it.
Source: Earnings report, October 14, 2026Rating reaffirmed ›
UBS kept its Buy rating on October 15, 2026.
Source: Analyst action, UBS, October 15, 2026
- The two nearest levels to watch are the 52-week high at $1,187.17, which sits above the price, and the 20-day EMA at $1,105.62, which sits below it.
- A 14-day RSI of 57.4 lands in the neutral zone, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- BLK beat estimates in 6 of the 6 reports in our data. After the October 14, 2026 report, the share price rose 4.38% in the first session.
BLK sits above its 50-day and 200-day moving averages ($1,103.45 and $1,062.34), which is why the trend reads up. A break below the 50-day would be the first sign of weakness. The closest level beneath the price is the 20-day EMA, at $1,105.62.
The next level above the price is the 52-week high at $1,187.17.
Technical indicators
Momentum and trend for BLK, from its daily closes.
As of October 26, 2026, with BLK at $1,127.66, its 14-day RSI is 57.4 (neutral territory), its 50-day simple moving average is $1,103.45 and its 200-day is $1,062.34.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What BLK moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, BLK's 1-year correlation of daily returns is +0.67 with S&P 500 (SPY), +0.55 with Nasdaq 100 (QQQ), +0.35 with Bitcoin (BTC) and +0.14 with gold (XAU).
BLK price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
16 of 18 analysts rate it a buy or strong buy, 2 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $1,310.00 is 16.2% above the price.More buy ratings than three months ago ›
16 of 18 rate it a buy now, against 15 of 17 three months ago.
BLK Wall Street View
12-month price targets
The price, $1,127.66, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 15, 2026 | UBS | Maintains | Buy |
| Oct 15, 2026 | Morgan Stanley | Maintains | Overweight |
| Oct 15, 2026 | JP Morgan | Maintains | Overweight |
| Oct 15, 2026 | Barclays | Maintains | Overweight |
| Oct 15, 2026 | Wells Fargo | Maintains | Overweight |
| Oct 15, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform |
As of October 26, 2026, 18 Wall Street analysts cover BLK: 16 rate it a buy or strong buy, 2 a hold and 0 a sell or strong sell. Their 12-month price targets range from $1,212.00 to $1,531.00. The median BLK price target is $1,310.00, 16.2% above the price of $1,127.66.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
BLK trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
BLK trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from BLK's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much BLK tends to move, against the market and on its own.
BLK price history and drawdowns
BLK's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.44% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 40.4%, from November 2021 to September 2022, regained by September 2024.Most 1-year holds ended higher ›
73% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $42,312, against $42,015 in the S&P 500 (SPY).
BLK Drawdowns & Recovery
As of October 26, 2026, BLK's worst peak-to-trough fall over the last 10 years with dividends reinvested was -40.4% (November 2021 to September 2022); it regained that peak by September 2024, 24 months after the low, and 73% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into BLK in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: BLK beat the S&P 500 over this period: $42,312 against $42,015.
A $10,000 investment in BLK in October 2016 would be worth about $42,312 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to BLK, and which have not.
Strongest month, November: an average of +6.78%, up in 8 of 10 years.
Weakest month, March: an average of -2.26%, up in 3 of 10 years.
This month, October: has averaged +2.51%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, BLK's strongest calendar month has been November (average +6.78%, up in 8 of 10 years) and its weakest March (average -2.26%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
BLK stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in BLK, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in BLK today could grow to about $13,923 by 2030 in the base case, with a 90th-percentile outcome near $28,498 and a 10th-percentile outcome around $6,802. The simulation models price only; at today's 1.99% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
BLK Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $1,570 for BLK by 2030 in the base case, from $1,128 today (1.4x over 4 years). The 10th-percentile path ends near $767. These are outcomes of a Monte Carlo simulation run on BLK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $856 | $1,225 | $1,752 | |
| 2028 | $802 | $1,331 | $2,208 | |
| 2029 | $777 | $1,445 | $2,688 | |
| 2030 | $767 | $1,570 | $3,214 |
Method: a lognormal simulation of BLK's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
BLK insider trading
What the people running the company have bought and sold.
BLK insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought BLK shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, BLK insiders reported 17 open-market sales worth $296.0M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Pamela Daley
Director
|
Grant | 27 | - |
| Sep 30, 2026 | William E Ford
Director
|
Grant | 34 | - |
| Sep 30, 2026 | Fabrizio Freda
Director
|
Grant | 18 | - |
| Sep 30, 2026 | Margaret L Johnson
Director
|
Grant | 33 | - |
| Sep 30, 2026 | Gregg Lemkau
Director
|
Grant | 27 | - |
| Sep 30, 2026 | Kathleen Murphy
Director
|
Grant | 36 | - |
| Sep 30, 2026 | Amin H Nasser
Director
|
Grant | 27 | - |
| Sep 30, 2026 | Gordon Melbourne Nixon,
Director
|
Grant | 34 | - |
| Sep 30, 2026 | Kristin C Peck
Director
|
Grant | 30 | - |
| Sep 30, 2026 | Charles H Robbins
Director
|
Grant | 27 | - |
| Sep 30, 2026 | Hans Erik Vestberg
Director
|
Grant | 33 | - |
| Jul 21, 2026 | Laurence D Fink
Chief Executive Officer
|
Grant | 7.9K | - |
| Jul 16, 2026 | Christopher J Meade
General Counsel
|
Sell | 18.1K | $19.9M |
| Jul 16, 2026 | Laurence D Fink
Chief Executive Officer
|
Sell | 1.9K | $2.1M |
| Jul 16, 2026 | Christopher J Meade
General Counsel
|
Option | 18.1K | $9.3M |
| Jun 30, 2026 | Pamela Daley
Director
|
Grant | 30 | - |
| Jun 30, 2026 | William E Ford
Director
|
Grant | 37 | - |
| Jun 30, 2026 | Fabrizio Freda
Director
|
Grant | 21 | - |
| Jun 30, 2026 | Margaret L Johnson
Director
|
Grant | 36 | - |
| Jun 30, 2026 | Gregg Lemkau
Director
|
Grant | 30 | - |
| Jun 30, 2026 | Kathleen Murphy
Director
|
Grant | 41 | - |
| Jun 30, 2026 | Amin H Nasser
Director
|
Grant | 30 | - |
| Jun 30, 2026 | Gordon Melbourne Nixon,
Director
|
Grant | 37 | - |
| Jun 30, 2026 | Kristin C Peck
Director
|
Grant | 34 | - |
| Jun 30, 2026 | Charles H Robbins
Director
|
Grant | 30 | - |
| Jun 30, 2026 | Hans Erik Vestberg
Director
|
Grant | 36 | - |
| Jun 1, 2026 | Laurence D Fink
Chief Executive Officer
|
Grant | 4.8K | - |
| Apr 28, 2026 | Laurence D Fink
Chief Executive Officer
|
Sell | 33.9K | $35.6M |
| Apr 27, 2026 | Robert S Kapito
President
|
Sell | 8.7K | $9.2M |
| Mar 31, 2026 | Pamela Daley
Director
|
Grant | 40 | - |
| Mar 31, 2026 | William E Ford
Director
|
Grant | 38 | - |
| Mar 31, 2026 | Fabrizio Freda
Director
|
Grant | 21 | - |
| Mar 31, 2026 | Margaret L Johnson
Director
|
Grant | 37 | - |
| Mar 31, 2026 | Gregg Lemkau
Director
|
Grant | 29 | - |
| Mar 31, 2026 | Kathleen Murphy
Director
|
Grant | 40 | - |
| Mar 31, 2026 | Amin H Nasser
Director
|
Grant | 30 | - |
| Mar 31, 2026 | Gordon Melbourne Nixon,
Director
|
Grant | 38 | - |
| Mar 31, 2026 | Kristin C Peck
Director
|
Grant | 34 | - |
| Mar 31, 2026 | Charles H Robbins
Director
|
Grant | 30 | - |
| Mar 31, 2026 | Hans Erik Vestberg
Director
|
Grant | 36 | - |
| Feb 24, 2026 | J Richard Kushel
Officer
|
Sell | 2.4K | $2.6M |
| Feb 23, 2026 | Stephen Cohen
Officer
|
Sell | 225 | $240.7K |
| Feb 19, 2026 | Stephen Cohen
Officer
|
Grant | 657 | - |
| Feb 13, 2026 | Robert L Goldstein
Chief Operating Officer
|
Grant | 8.6K | - |
| Feb 11, 2026 | Robert L Goldstein
Chief Operating Officer
|
Sell | 59.5K | $64.7M |
| Feb 11, 2026 | Stephen Cohen
Officer
|
Sell | 2.2K | $2.3M |
| Feb 10, 2026 | Robert L Goldstein
Chief Operating Officer
|
Option | 54.2K | $27.8M |
| Feb 4, 2026 | Margaret L Johnson
Director
|
Grant | 419 | - |
| Jan 30, 2026 | Stephen Cohen
Officer
|
Grant | 3.8K | - |
| Jan 30, 2026 | Marc D Comerchero
Officer
|
Grant | 549 | - |
| Jan 30, 2026 | Laurence D Fink
Chief Executive Officer
|
Grant | 19.9K | - |
| Jan 30, 2026 | Robert L Goldstein
Chief Operating Officer
|
Grant | 9.2K | - |
| Jan 30, 2026 | Caroline Heller
Officer
|
Grant | 627 | - |
| Jan 30, 2026 | Robert S Kapito
President
|
Grant | 15.3K | - |
| Jan 30, 2026 | J Richard Kushel
Officer
|
Grant | 6.3K | - |
| Jan 30, 2026 | Rachel Lord
Officer
|
Grant | 6.3K | - |
| Jan 30, 2026 | Christopher J Meade
General Counsel
|
Grant | 5.2K | - |
| Jan 30, 2026 | Martin Small
Chief Financial Officer
|
Grant | 5.3K | - |
| Jan 27, 2026 | Gregg Lemkau
Director
|
Grant | 225 | - |
| Jan 21, 2026 | J Richard Kushel
Officer
|
Sell | 20.0K | $22.5M |
| Jan 21, 2026 | J Richard Kushel
Officer
|
Option | 20.0K | $10.3M |
| Jan 16, 2026 | Martin Small
Chief Financial Officer
|
Sell | 27.0K | $31.7M |
| Jan 16, 2026 | Stephen Cohen
Officer
|
Grant | 2.6K | - |
| Jan 16, 2026 | Marc D Comerchero
Officer
|
Grant | 730 | - |
| Jan 16, 2026 | Laurence D Fink
Chief Executive Officer
|
Grant | 7.2K | - |
| Jan 16, 2026 | Fabrizio Freda
Director
|
Grant | 214 | - |
| Jan 16, 2026 | Murry S Gerber
Director
|
Grant | 214 | - |
| Jan 16, 2026 | Robert L Goldstein
Chief Operating Officer
|
Grant | 4.3K | - |
| Jan 16, 2026 | Caroline Heller
Officer
|
Grant | 1.2K | - |
| Jan 16, 2026 | Margaret L Johnson
Director
|
Grant | 214 | - |
| Jan 16, 2026 | Robert S Kapito
President
|
Grant | 5.1K | - |
| Jan 16, 2026 | J Richard Kushel
Officer
|
Grant | 2.2K | - |
| Jan 16, 2026 | Rachel Lord
Officer
|
Grant | 2.3K | - |
| Jan 16, 2026 | Christopher J Meade
General Counsel
|
Grant | 2.5K | - |
| Jan 16, 2026 | Cheryl D Mills
Director
|
Grant | 214 | - |
| Jan 16, 2026 | Kathleen Murphy
Director
|
Grant | 214 | - |
| Jan 16, 2026 | Martin Small
Chief Financial Officer
|
Option | 27.0K | $13.9M |
| Jan 16, 2026 | Martin Small
Chief Financial Officer
|
Grant | 4.3K | - |
| Jan 16, 2026 | Hans Erik Vestberg
Director
|
Grant | 214 | - |
| Jan 16, 2026 | Susan L Wagner
Director
|
Grant | 214 | - |
| Jan 16, 2026 | Mark A Wilson
Director
|
Grant | 214 | - |
| Dec 31, 2025 | Pamela Daley
Director
|
Grant | 36 | - |
| Dec 31, 2025 | William E Ford
Director
|
Grant | 34 | - |
| Dec 31, 2025 | Fabrizio Freda
Director
|
Grant | 18 | - |
| Dec 31, 2025 | Margaret L Johnson
Director
|
Grant | 32 | - |
| Dec 31, 2025 | Kathleen Murphy
Director
|
Grant | 33 | - |
| Dec 31, 2025 | Amin H Nasser
Director
|
Grant | 27 | - |
| Dec 31, 2025 | Gordon Melbourne Nixon,
Director
|
Grant | 34 | - |
| Dec 31, 2025 | Kristin C Peck
Director
|
Grant | 30 | - |
| Dec 31, 2025 | Charles H Robbins
Director
|
Grant | 27 | - |
| Dec 31, 2025 | Hans Erik Vestberg
Director
|
Grant | 33 | - |
| Dec 2, 2025 | Adebayo O Ogunlesi
Director
|
Grant | 28.6K | - |
| Dec 1, 2025 | Martin Small
Chief Financial Officer
|
Sell | 1.3K | $1.3M |
| Nov 13, 2025 | Robert S Kapito
President
|
Grant | 1.0K | - |
| Oct 20, 2025 | Rachel Lord
Officer
|
Sell | 12.0K | $14.0M |
| Sep 30, 2025 | Pamela Daley
Director
|
Grant | 34 | - |
| Sep 30, 2025 | William E Ford
Director
|
Grant | 31 | - |
| Sep 30, 2025 | Fabrizio Freda
Director
|
Grant | 24 | - |
| Sep 30, 2025 | Margaret L Johnson
Director
|
Grant | 30 | - |
| Sep 30, 2025 | Kathleen Murphy
Director
|
Grant | 286 | - |
| Sep 30, 2025 | Amin H Nasser
Director
|
Grant | 24 | - |
| Sep 30, 2025 | Gordon Melbourne Nixon,
Director
|
Grant | 31 | - |
| Sep 30, 2025 | Kristin C Peck
Director
|
Grant | 28 | - |
| Sep 30, 2025 | Charles H Robbins
Director
|
Grant | 24 | - |
| Sep 30, 2025 | Hans Erik Vestberg
Director
|
Grant | 30 | - |
| Jul 30, 2025 | J Richard Kushel
Officer
|
Sell | 17.1K | $19.2M |
| Jul 30, 2025 | J Richard Kushel
Officer
|
Option | 17.1K | $8.8M |
| Jul 25, 2025 | Laurence D Fink
Chief Executive Officer
|
Sell | 26.9K | $30.2M |
| Jul 25, 2025 | Rachel Lord
Officer
|
Sell | 18.0K | $20.3M |
| Jul 25, 2025 | Rachel Lord
Officer
|
Option | 18.0K | $9.3M |
| Jul 24, 2025 | Fabrizio Freda
Director
|
Sell | 4.4K | $5.0M |
| Jul 24, 2025 | Susan L Wagner
Director
|
Grant | 90 | - |
| Jul 17, 2025 | Laurence D Fink
Chief Executive Officer
|
Grant | 7.6K | - |
| Jun 30, 2025 | Pamela Daley
Director
|
Grant | 40 | - |
| Jun 30, 2025 | William E Ford
Director
|
Grant | 35 | - |
| Jun 30, 2025 | Fabrizio Freda
Director
|
Grant | 28 | - |
| Jun 30, 2025 | Margaret L Johnson
Director
|
Grant | 34 | - |
| Jun 30, 2025 | Kathleen Murphy
Director
|
Grant | 23 | - |
| Jun 30, 2025 | Amin H Nasser
Director
|
Grant | 28 | - |
| Jun 30, 2025 | Gordon Melbourne Nixon,
Director
|
Grant | 35 | - |
Source: TwelveData, from SEC Form 4 filings
BLK stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.